These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Activity and content of antioxidant enzymes in prostate tumors. Kotrikadze N; Alibegashvili M; Zibzibadze M; Abashidze N; Chigogidze T; Managadze L; Artsivadze K Exp Oncol; 2008 Sep; 30(3):244-7. PubMed ID: 18806750 [TBL] [Abstract][Full Text] [Related]
23. Do younger men have better biochemical outcomes after radical prostatectomy? Freedland SJ; Presti JC; Kane CJ; Aronson WJ; Terris MK; Dorey F; Amling CL; Urology; 2004 Mar; 63(3):518-22. PubMed ID: 15028449 [TBL] [Abstract][Full Text] [Related]
24. Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A. Sciarra A; Voria G; Monti S; Mazzone L; Mariotti G; Pozza M; D'Eramo G; Silverio FD Prostate; 2004 Mar; 58(4):421-8. PubMed ID: 14968443 [TBL] [Abstract][Full Text] [Related]
25. [Effect of alpha-lipoic acid preparations on bilirubin and transferrin levels and ferritin iron and transferrin iron content]. Dudchenko NO; Mykhaĭlik OM; Lubianova IP Ukr Biokhim Zh (1999); 2001; 73(2):102-5. PubMed ID: 11642031 [TBL] [Abstract][Full Text] [Related]
26. EPR study of serum ceruloplasmin and iron transferrin in myocardial infarction. Bomba M; Camagna A; Cannistraro S; Indovina PL; Samoggia P Physiol Chem Phys; 1977; 9(2):175-80. PubMed ID: 202979 [TBL] [Abstract][Full Text] [Related]
27. [EPR study of iron status in human body during intensive physical activity]. Ibragimova MI; Chushnikov AI; Cherepnev GV; Petukhov VIu; Zheglov EP Biofizika; 2014; 59(3):520-6. PubMed ID: 25715595 [TBL] [Abstract][Full Text] [Related]
28. Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate. Lerner SE; Jacobsen SJ; Lilja H; Bergstralh EJ; Ransom J; Klee GG; Piironen T; Blute ML; Lieber MM; Zincke H; Pettersson K; Peterson D; Oesterling JE Urology; 1996 Aug; 48(2):240-8. PubMed ID: 8753736 [TBL] [Abstract][Full Text] [Related]
29. Electron paramagnetic resonance study of storage effects on ceruloplasmin in human serum compared with purified ceruloplasmin in aqueous solution. Onori S; Rosati A; Cannistraro S Physiol Chem Phys; 1981; 13(5):439-46. PubMed ID: 6280218 [TBL] [Abstract][Full Text] [Related]
30. [The role of oxidative metabolism disturbance in the development of NO-related endothelial dysfunction during chronic hearth failure]. Goishvili N; Kakauridze N; Sanikidze T Georgian Med News; 2005 May; (122):65-8. PubMed ID: 15988088 [TBL] [Abstract][Full Text] [Related]
31. PSA measurement following prostatectomy: an unexpected error. Descotes JL; Legeais D; Gauchez AS; Long JA; Rambeaud JJ Anticancer Res; 2007; 27(2):1149-50. PubMed ID: 17465255 [TBL] [Abstract][Full Text] [Related]
32. Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy. Alessandro S; Vincenzo G; Maria AG; Stefano S; Alessandro G; Salvatore M; Vincenzo T; Franco DS Endocr Relat Cancer; 2007 Sep; 14(3):625-32. PubMed ID: 17914093 [TBL] [Abstract][Full Text] [Related]
33. Extremely high PSA (250ng/ml) in a patient with localised prostatic carcinoma. Colgan G; O'Brien MF; Ahmad I; Thornhill JA Ir Med J; 2005 Jan; 98(1):29. PubMed ID: 15782735 [No Abstract] [Full Text] [Related]
34. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714 [TBL] [Abstract][Full Text] [Related]
35. Prostate carcinoma with peripheral metastases after prostatectomy and low levels of serum prostate specific antigen. Seven B; Varoglu E; Cayir K; Sahin A; Kantarci M Hell J Nucl Med; 2008; 11(1):53-4. PubMed ID: 18392233 [No Abstract] [Full Text] [Related]
36. Characteristics of morphological change in erythrocytes during metaststic adenocarcinoma of the prostate before and after castration. Veshapidze N; Alibegashvili M; Gabunia N; Chigogidze T; Managadze L Georgian Med News; 2009; (172-173):10-3. PubMed ID: 19644180 [TBL] [Abstract][Full Text] [Related]
37. High dose hook effect in serum total and free prostate specific antigen in a patient with metastatic prostate cancer. Furuya Y; Cho S; Ohta S; Sato N; Kotake T; Masai M J Urol; 2001 Jul; 166(1):213. PubMed ID: 11435864 [No Abstract] [Full Text] [Related]
38. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate. Bhatti RA; Ablin RJ; Condoulis W; Guinan PD Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662 [TBL] [Abstract][Full Text] [Related]